Similar Papers

Paper Title
Journal
Date
Author
Pre-treatment 18F-FDG-PET/CT parameters as biomarkers for progression free survival, best overall response and overall survival in metastatic melanoma patients undergoing first-line immunotherapy.
Felix Peisen ... Konstantin Nikolaou
PLOS ONE | VOL. 19
Felix Peisen, et. al.Felix Peisen ... Konstantin Nikolaou
05 Jan 2024
Abstract A29: Multilevel factors associated with increased in-hospital length of stay among patients following head and neck cancer treatment
Eric Adjei Boakye ... Nosayaba Osazuwa-Peters
Cancer Epidemiology, Biomarkers & Prevention | VOL. 27
Eric Adjei Boakye, et. al.Eric Adjei Boakye ... Nosayaba Osazuwa-Peters
01 Jul 2018
Assessing lymphatic response to treatments in head and neck cancer using near-infrared fluorescence imaging
I-Chih Tan ... Eva M Sevick-Muraca
-
I-Chih Tan, et. al.I-Chih Tan ... Eva M Sevick-Muraca
19 May 2014
Abstract 3405: Characterizing treatment response in head and neck cancer through viral ctDNA quantification and fragment length
Sarah Tadhg Ferrier ... Thupten Tsering
Cancer Research | VOL. 82
Sarah Tadhg Ferrier, et. al.Sarah Tadhg Ferrier ... Thupten Tsering
15 Jun 2022
View more papers

More From: EJC Supplements

Paper Title
Journal
Date
Author
Immunotherapies in ovarian cancer
Elena García-Martínez ... J Alejandro Pérez-Fidalgo
EJC Supplements | VOL. 15
Elena García-Martínez, et. al.Elena García-Martínez ... J Alejandro Pérez-Fidalgo
01 Aug 2020
Anti-angiogenic therapy for ovarian cancer
Yolanda García García ... Clara Martínez Vila
EJC Supplements | VOL. 15
Yolanda García García, et. al.Yolanda García García ... Clara Martínez Vila
01 Aug 2020
Editorial board
-
EJC Supplements | VOL. 13
--
01 Dec 2015
Biosimilars: Extrapolating the evidence. A roundtable discussion
Bradley J Monk ... George Somlo
EJC Supplements | VOL. 13
Bradley J Monk, et. al.Bradley J Monk ... George Somlo
01 Dec 2015
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.